← Back to Search

Behavioural Intervention

Produce Prescription for Type 2 Diabetes (PPT2D Trial)

N/A
Waitlist Available
Led By Carmen Byker Shanks, PhD
Research Sponsored by Gretchen Swanson Center for Nutrition
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Diagnosed with Type 2 diabetes
≥ 18 years of age
Timeline
Screening 3 weeks
Treatment Varies
Follow Up months 1-2, 7-8
Awards & highlights

PPT2D Trial Summary

This trial aims to measure the impact of Produce Prescription Projects on type 2 diabetes-related outcomes in those with low-income. It will assess primary outcomes like Fruit and Vegetable Intake and Hemoglobin A1c, as well as food security & healthcare utilization.

Who is the study for?
This trial is for adults over 18 with Type 2 diabetes who are low-income, eligible for Medicaid or SNAP benefits, and have food insecurity. It's not open to those who are pregnant, nursing, or planning to move during the study.Check my eligibility
What is being tested?
The trial tests a Produce Prescription program that helps low-income individuals with Type 2 diabetes buy fruits and vegetables. The impact on blood sugar control (HbA1c), diet quality, food security, and healthcare costs will be studied.See study design
What are the potential side effects?
Since this intervention involves dietary changes by increasing fruit and vegetable intake through financial incentives rather than medication or medical procedures, no direct side effects are expected from the Produce Prescription itself.

PPT2D Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been diagnosed with Type 2 diabetes.
Select...
I am 18 years old or older.

PPT2D Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~months 1-2, 7-8
This trial's timeline: 3 weeks for screening, Varies for treatment, and months 1-2, 7-8 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Hemoglobin A1c
Secondary outcome measures
Blood pressure
Body Mass Index
Diabetes distress
+6 more
Other outcome measures
Cost-effectiveness (HbA1c -1%)
Cost-effectiveness (HbA1c <7%)
Dose delivered
+6 more

PPT2D Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention ArmExperimental Treatment1 Intervention
Intervention arm participants will receive produce prescription services for a defined period of time (4-6months)
Group II: Control ArmActive Control1 Intervention
Control arm participants will not receive produce prescriptions but will receive standard of care services for diabetes management

Find a Location

Who is running the clinical trial?

University of Colorado, DenverOTHER
1,752 Previous Clinical Trials
2,164,999 Total Patients Enrolled
University of California, San FranciscoOTHER
2,518 Previous Clinical Trials
15,241,129 Total Patients Enrolled
Lawndale Christian Health CenterUNKNOWN
~86 spots leftby Aug 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top